Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2024-11-08 00:00:00 ET · period of report 2023-01-03 · accession 0001104659-24-115837 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-08 | 2024-11-07 | NVCT | Carson Michael J. | VP, Fin | S - Sale | $8.16 | -2,755 | 87.9K | -3% | -$22.5K | |
| M | 2024-11-08 | 2023-01-03+ | NVCT | Carson Michael J. | VP, Fin | A - Grant | $0.00 | +63.4K | 90.7K | +232% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | S | D | 2,755 | $8.16 | 87,918 | D | — | — | (F2) Includes shares of restricted common stock, which vest over various time periods. |
| 2 | Common | Common Stock | 2023-01-03 | A | A | 28,806 | $0.00 | 56,106 | D | — | — | (F1) The 28,806 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates. (F2) Includes shares of restricted common stock, which vest over various time periods. |
| 3 | Common | Common Stock | 2024-01-04 | A | A | 34,567 | $0.00 | 90,673 | D | — | — | (F3) The 34,567 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates. (F2) Includes shares of restricted common stock, which vest over various time periods. |